Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

ClinicalTrials.gov ID: NCT07175428

Public ClinicalTrials.gov record NCT07175428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 9:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Multicenter, Open-label, Blinded-endpoint Study to Evaluate the Safety of REGN7508 and REGN9933, Monoclonal Antibodies Against FXI, Versus Apixaban in Participants With Atrial Fibrillation (ROXI-ATLAS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how well REGN7508 and REGN9933 work in patients that get medicine for their atrial fibrillation. The bleeding effects of REGN7508 and REGN9933 will be compared to another medicine (apixaban), which is available on the market to treat and prevent formation of blood clots. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well do the study drugs reduce the risk of having a stroke * How much of REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the drugs less effective or could lead to side effects)

Study identification

NCT ID
NCT07175428
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
1,200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2025
Primary completion
Feb 8, 2027
Completion
Apr 20, 2027
Last update posted
Aug 19, 2026

2025 – 2027

United States locations

U.S. sites
43
U.S. states
16
U.S. cities
39
Facility City State ZIP Site status
SEC Clinical Research Dothan Alabama 36305 Recruiting
Eastern Shore Research Institute Fairhope Alabama 36532 Recruiting
Valley Clinical Trials, Inc Covina California 91723 Recruiting
North Coast Cardiology Encinitas California 92024 Recruiting
Mission Cardiovascular Research Institute Fremont California 94538 Recruiting
National Institute of California Heart and Vein Specialists Huntington Beach California 92648 Recruiting
Profound Research LLC at Southern California Heart Specialists Pasadena California 91105 Recruiting
Empire Clinical Research Pomona California 91767 Recruiting
The Cardiovascular Center Redding California 96001 Recruiting
Northbay Clinical Research Center Santa Rosa California 95405 Recruiting
Cardiology Associates Medical Group Ventura California 93003 Recruiting
Interventional Cardiology Medical Group West Hills California 91307 Recruiting
Nouvelle Clinical Research LLC Cutler Bay Florida 33189 Recruiting
South Florida Research Organization LLC Medley Florida 33166 Recruiting
Inpatient Research Clinic LLC Miami Lakes Florida 33014 Recruiting
Cardiovascular Center of Sarasota Foundation for Research and Education Sarasota Florida 34239 Recruiting
Clinical Site Partners, LLC DBA Flourish Research Winter Park Florida 32789 Recruiting
Grady Health System Atlanta Georgia 30303 Recruiting
Health Sciences Research Building II Atlanta Georgia 30322 Withdrawn
NSC Research, Inc Johns Creek Georgia 30024 Recruiting
Indiana University Indianapolis Indiana 46202 Recruiting
Blue Coast Research Center, LLC Indianapolis Indiana 46237 Recruiting
Franciscan Physician Network, Indiana Heart Physicians Indianapolis Indiana 46237 Recruiting
Indiana Medical Research Merrillville Indiana 46410 Recruiting
Reid Physician Associates Richmond Indiana 47374 Recruiting
Monroe Research, LLC West Monroe Louisiana 71291 Recruiting
Anderson Medical Research Ft. Washington Maryland 20744 Recruiting
Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC) Boston Massachusetts 02215 Recruiting
Profound Research, Millennium Cardiology Farmington Hills Michigan 48334 Recruiting
AA Medical Research Center (MRC) Flint Michigan 48504 Recruiting
Fairview Health Services Maplewood Minnesota 55109 Recruiting
Moses Cone Hospital Operating Corporation dba Cone Health, Lebauer-Brodie Center for Cardiovascular Research Greensboro North Carolina 27401 Recruiting
K&R Research LLC Marion Ohio 43302 Recruiting
Advanced Medical Research Maumee Ohio 43537 Recruiting
Monument Health Clinical Research Rapid City South Dakota 57701 Recruiting
East Coast Institute for Research, Jefferson City Jefferson City Tennessee 37760 Recruiting
PharmaTex Research Amarillo Texas 79106 Recruiting
Complete Heart Care P.A. McKinney Texas 75071 Recruiting
Texas Institute of Cardiology PA McKinney Texas 75071 Recruiting
Synergy Group Medical, LLC Missouri City Texas 77459 Recruiting
Permian Research Foundation Odessa Texas 79761 Recruiting
Tyler Cardiovascular Consultants Tyler Texas 75701 Recruiting
Alpine Research TC Clinton Utah 84015 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07175428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07175428 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →